Overview
NICE is unable to make a recommendation on SQ HDM SLIT (Acarizax) for treating allergic rhinitis and allergic asthma in adults caused by house dust mites. This is because ALK-Abello did not provide an evidence submission. We will review this decision if the company decides to make a submission.
Guidance development process
How we develop NICE technology appraisal guidance
This technology appraisal guidance is now being reviewed as SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites [ID6280].